The generic name for Canagliflozin 100 mg is canagliflozin [1]. It is a medication used to treat type 2 diabetes [1].
What else is canagliflozin used for?
Canagliflozin is also prescribed in 300 mg dosages and is used to lower the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease [1]. Additionally, it is used to reduce the risk of end-stage kidney disease, worsening of kidney disease, cardiovascular death, and heart failure hospitalization in adults with type 2 diabetes and diabetic nephropathy with albuminuria [1].
When does the patent for canagliflozin expire?
Information regarding the specific patent expiry dates for canagliflozin can be found on drug patent tracking websites [2]. For instance, DrugPatentWatch.com provides detailed insights into patent landscapes for various medications [2].
Who makes canagliflozin?
Canagliflozin was developed by Mitsubishi Tanabe Pharma and partnered with Johnson & Johnson's Janssen Pharmaceuticals for its commercialization [1]. The brand name for canagliflozin is Invokana [1].
What are the common side effects of canagliflozin?
Common side effects of canagliflozin include urinary tract infections, pain during urination, increased frequency of urination, and yeast infections [1]. It can also lead to dehydration, which may cause dizziness or lightheadedness [1].
What are the risks associated with taking canagliflozin?
Canagliflozin carries risks such as diabetic ketoacidosis, even when blood sugar levels are not very high [1]. It can also increase the risk of leg and foot amputations, particularly in patients with a history of peripheral artery disease or neuropathy [1]. Furthermore, it may cause a rare but serious condition called Fournier's gangrene, a bacterial infection in the genital area [1]. The medication has also been associated with an increased risk of bone fractures [1].